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Formation of mixed disulfides between glutathione and the cys-
teines of some proteins (glutathionylation) has been suggested as
a mechanism through which protein functions can be regulated by
the redox status. The aim of this study was to identify the proteins
of T cell blasts that undergo glutathionylation under oxidative
stress. To this purpose, we radiolabeled cellular glutathione with
35S, exposed T cells to oxidants (diamide or hydrogen peroxide),
and performed nonreducing, two-dimensional electrophoresis fol-
lowed by detection of labeled proteins by phosphorimaging and
their identification by mass spectrometry techniques. We detected
several proteins previously not recognized to be glutathionylated,
including cytoskeletal proteins (vimentin, myosin, tropomyosin,
cofilin, profilin, and the already known actin), enzymes (enolase,
aldolase, 6-phosphogluconolactonase, adenylate kinase, ubiquitin-
conjugating enzyme, phosphoglycerate kinase, triosephosphate
isomerase, and pyrophosphatase), redox enzymes (peroxiredoxin
1, protein disulfide isomerase, and cytochrome c oxidase), cyclo-
philin, stress proteins (HSP70 and HSP60), nucleophosmin, trans-
gelin, galectin, and fatty acid binding protein. Based on the
presence of several protein isoforms in control cells, we suggest
that enolase and cyclophilin are heavily glutathionylated under
basal conditions. We studied the effect of glutathionylation on
some of the enzymes identified in the present study and found that
some of them (enolase and 6-phosphogluconolactonase) are in-
hibited by glutathionylation, whereas the enzymatic activity of
cyclophilin (peptidylprolyl isomerase) is not. These findings sug-
gest that protein glutathionylation might be a common mechanism
for the global regulation of protein functions.
Formation of mixed disulfides between glutathione and cys-teines in proteins (glutathionylation) has long been known to
occur after oxidative stress (1). Recently, protein glutathiony-
lation has gained attention as a possible means of redox regu-
lation of protein functions.
Glutathionylation takes place by thiol-disulfide exchange be-
tween protein sulfhydryls and oxidized glutathione (GSSG), a
reversible process that can be catalyzed by glutaredoxin. GSSG
reduced glutathione (GSH) ratio is an indicator of the redox
status of the cell, and the extent of protein glutathionylation will
vary accordingly: a higher ratio will promote glutathionylation
binding, a lower ratio will result in deglutathionylationrelease
of glutathione. This finding also suggests a likely compartmen-
talization of protein glutathionylation, as GSSGGSH ratio is
very high in the endoplasmic reticulum, where an oxidizing
environment favors sulfhydryl oxidation (2). Glutathionylated
proteins also can be formed by reaction with S-nitrosogluta-
thione, a pathway requiring the formation of this compound
from nitric oxide (3).
A number of proteins have been reported to undergo gluta-
thionylation, including enzymes, transcription factors, and on-
cogenes (reviewed in ref. 4). The identification of glutathiony-
lated proteins is hampered by the lack of specific antibodies to
modified cysteines that would allow detecting glutathionylated
proteins by immunoblotting, in analogy with the protocols for
the study of phosphorylated proteins.
Typically, proteome analysis using two-dimensional gel elec-
trophoresis followed by MS fingerprintingsequencing can be
used to identify modified proteins. A similar approach has been
used to identify carbonyl-modified proteins after oxidative stress
in yeast after one-dimensional PAGE (5) and, using two-
dimensional gels, to identify vitellogenin as a major oxidized
protein in aging Caenorhabditis elegans (6). More recently this
technique was applied to the analysis of Alzheimer’s disease
brains and led to the identification of -actin and creatine kinase
as the two major carbonylated proteins. Finally, a technique was
set up to detect S-nitrosylated proteins in neuronal cells and led
to the finding of several targets for S-nitrosylation (7).
Several T lymphocyte functions are known to be sensitive to
the GSH status (8, 9), and GSH depletion has been demon-
strated in AIDS patients, suggesting the replenishment of GSH
levels as a possibly useful pharmacological strategy. Increased
protein glutathionylation likely plays a role in GSH depletion
observed in T lymphocytes from AIDS patients (10).
35S labeling of cells has been used by Johnston and associates (11)
in their earlier studies of glutathionylated protein metabolism in
phagocytes. More recently, this technique was applied to study
tumor necrosis factor-induced glutathionylation in HeLa cells and
allowed the identification of annexin II and thioredoxin peroxidase
II as proteins subject to glutathionylation (12).
We have used an approach that combines 35S labeling of
intracellular glutathione followed by proteome analysis using
nonreducing, two-dimensional electrophoresis and MS finger-
printing to identify specific glutathionylated proteins in human
T cell blasts exposed to oxidative stress (diamide or hydrogen
peroxide). This model was previously reported to cause extensive
S-thiolation of cellular proteins (36).
Materials and Methods
T Cell Blasts. Human peripheral blood mononuclear cells (PBMC)
were isolated by using standard FicollHypaque gradients from
buffy coats of healthy donors kindly provided by the Blood
Center of the Hospital of Magenta, Magenta, Italy. PBMC were
cultured at 1  106ml for 3 days in RPMI 1640 with 10% FCS
and 2 gml phytohemagglutinin (Sigma), then washed and
cultured for 3 days with 50 unitsml human recombinant IL-2
(Chiron).
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Cell Labeling and Exposure to Oxidants. Cells were resuspended at
3.3  106ml and maintained throughout the experiment in
Hanks’ balanced salt solution (HBSS) containing 50 gml
cycloheximide (CHX). After a 20-min preincubation in HBSS
CHX, the cells were incubated with 8 Ciml of L-[35S] cysteine
(specific activity, 1,000 Cimmol; Amersham Pharmacia). After
30 min the cells were treated for 5 min with 1 mM diamide
(Sigma) or H2O2 (usually 1 mM, unless otherwise indicated).
The cells were then collected by centrifugation and either
processed for electrophoretic analysis as described below, or the
proteins were precipitated with trichloroacetic acid (TCA) at a
final concentration of 5% and filtered on GFB glass fiber filters.
After three washes with 5% TCA to remove all nonprotein-
bound 35S, the amount of TCA-precipitable radioactivity was
counted to assess the extent of S-thiolation induced by the
oxidants.
In some experiments, the cells were treated with 10 mM buthi-
onine sulfoximine for 30 min before and during incubation with
radioactive cysteine, to inhibit the synthesis of radiolabeled GSH.
Protein Electrophoresis. The cell pellet (2 107 cellssample) was
resuspended in Hanks’ balanced salt solutioncycloheximide
containing 50 mM N-ethylmaleimide, centrifuged, extracted
with chloroformmethanol, resuspended in 8 M urea  0.5%
carrier ampholytes, and run on immobilized pH gradients (IPG)
(13) covering exponentially the pH range 4 to 10 (14). IPG strips
were embedded on 12% polyacrylamide gel slabs for the second-
dimensional run in the discontinuous buffer system of Laemmli
(15). Electroporesis was carried out under nonreducing condi-
tions. The slabs were stained with Coomassie blue, and radio-
activity was analyzed with a PhosphorImager after drying. In one
experiment the protein extract of diamide-treated cells was
added with 50 mM DTT and run in SDSPAGE to confirm that
no aspecific incorporation of 35S could be detected under these
experimental conditions.
Protein Identification. The 35S-labeled and Coomassie-stained
protein spots were excised and washed twice during 10 min in a
mixture of acetonitrile50 mM NH4HCO3 in water (1:1 by
volume). Then the gel pieces were dried in vacuo and 1 g of
trypsin in 50–100 l of 50 mM NH4HCO3 solution was added.
The digestion was allowed to proceed overnight at 37°C and was
terminated by the addition of 3 l formic acid.
The supernatant, containing the generated tryptic peptides,
was transferred into another Eppendorf tube and mixed with 3
l of a suspension of POROS 50-R2 beads in methanol (1
mgml). The beads preferentially adsorb the peptides, leaving
buffer salts in the supernatant, which was discarded after
centrifugation (16). These beads were again suspended in water,
and an aliquot was placed onto the matrix-assisted laser desorp-
tion ionization-target disk and allowed to dry in the air. Peptides
were desorbed on target with a solution of 4% -cyanocinnamic
acid and 1% 2,5-dihydroxybenzoic acid in 0.1% trif luoroacetic
acid in wateracetonitrile (1:1 by volume).
Peptide mass fingerprints were generated with a Bruker II
Reflex matrix-assisted laser desorption ionization-time of flight
mass spectrometer. Proteins were identified with the MASCOT
(Matrix Science, London) searching algorithms by using the
nonredundant database (17). Further confirmation of protein
identity was obtained by postsource-decay analysis of selected
peptide ions and analysis with the MASCOT searching algorithm.
Details are published elsewhere (16, 18). Because of blockage of
remaining reactive sulfhydril groups by N-ethylmaleimide, we
often noticed the formation of an important, and probably
quantitative, amount of the N-ethylmaleimide adduct (plus 143
atomic mass units) in addition to its open hydrolyzed form (plus
125 atomic mass units). Because these groups are easily ionized,
the corresponding peptides ions often appear as the dominant
ions.
Enzyme Assays. As a source of human enolase, a cytosolic
preparation obtained from human PBMC was prepared by lysing
PBMC (107 cells0.1 ml) in 1% Triton X-100, 50 mM EDTA.
Enolase activity was measured spectrophotometrically as de-
scribed (19). Recombinant human peptidylprolyl isomerase (cy-
clophilin A) was a kind gift from Barbara Sherry (Picower
Institute for Medical Research, Manhasset, NY). Its peptidyl-
prolyl cis-trans isomerase activity was measured as published
(20). Human recombinant 6-phosphogluconolactonase was pre-
pared, and its activity was assayed as described (21).
Results
To provide a global quantitative measure of protein glutathio-
nylation induced by exposure of T cell blasts to diamide or H2O2,
we measured the amount of trichloroacetic acid-precipitable
radioactivity. Five-minute exposure to 1 mM diamide resulted in
a marked incorporation of radioactivity (control, 4,290  1,550
cpm vs. diamide, 66,500  25,000 cpm; mean  SD of three
experiments). Most (95%) of this radioactivity was attributable
to S-thiolation as it was removed by DTT treatment (data not
shown) and was represented by protein-bound GSH as it was
reduced by 81  1% if buthionine sulfoximine, an inhibitor of
GSH synthesis, was added 30 min before the labeling step. A
15-min treatment with H2O2 induced S-thiolation, but to a lower
extent than diamide (maximal labeling was 10,690  1,360 cpm
vs. 66,500  25,000 cpm), with a plateau in the range of 100 M
to 10 mM H2O2 concentration. Under our experimental condi-
tions we observed no cytotoxicity of cycloheximide, diamide, or
H2O2, as judged by trypan blue exclusion (cell viability was
always 90%).
Fig. 1 shows the two-dimensional electrophoresis pattern of
protein glutathionylation by diamide and H2O2 in one experi-
ment, representative of three independent assays performed on
T cell blasts obtained from different donors. Coomassie blue-
stained maps are displayed in comparison with fluorography. It
can be seen that a number of proteins were already labeled under
basal conditions. It should be noted that this was not caused by
residual protein synthesis as no radioactive spots were visible
when we ran DTT-treated samples (not shown). However, in the
three independent experiments, the spots labeled under basal
conditions were not always the same, i.e., different proteins were
found thiolated under resting conditions in different donors. As
shown in Fig. 1, diamide, as expected, caused the labeling of a
large number of proteins, whereas fewer proteins were labeled
with H2O2. In the three experiments, the percentage of labeled
proteins over Coomassie stain positive spots was 5  2 in
controls; 55  20 in diamide-treated, and 17  11 in H2O2-
treated samples (mean  SD of three experiments). Some
labeled proteins, including one heavily labeled spot in control
cells, were not visible in Coomassie staining and could never be
identified by MS.
Table 1 presents an overview of all labeled proteins that could
be identified by MS in one or more of the three experiments (Fig.
1 refers to experiment 3), and a semiquantitative evaluation of
their labeling in the three experimental conditions (C, control;
D, diamide; H, H2O2). Fig. 2 identifies the spots corresponding
to the identified proteins in experiment 3 (diamide-treated cells).
A total of 38 proteins have been identified, and almost half of
them, 16, have been confirmed in at least two independent
experiments. The fact that in some cases we have found the
protein only once depends on the inter-individual differences on
the protein pattern or on differences in the labeling pattern.
Because many of the enzymes identified as glutathionylation
targets could contain cysteine residues in their active site or next
to it, we investigated the effect of glutathionylation on the
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activity of some of them. To this purpose, recombinant enzymes,
when available (peptidylprolyl isomerase and 6-phosphoglu-
conolactonase) or a crude PBMC cytosol (as a source of enolase)
were incubated for 90 min with 5 mM GSSG, or with 7.5 mM
GSSG in the case of 6-phosphogluconolactonase. The effect of
GSSG treatment on the activity of these enzymes is shown in
Table 2. Whereas 6-phosphogluconolactonase and enolase were
inhibited by glutathionylation, peptidylprolyl isomerase activity
of cyclophilin was unaffected although glutathionylation of
recombinant cyclophilin by GSSG was confirmed by matrix-
assisted laser desorption ionization-time of flight MS (not
shown).
Discussion
In this article we show that many proteins can undergo gluta-
thionylation under oxidative stress induced by either diamide or
H2O2.
A major group of glutathionylated proteins are enzymes
involved in various pathways of carbohydrateenergy metabo-
lism. This finding is in agreement with, and provides a molecular
mechanism for, previous reports by Gilbert (22) who showed that
the GSHGSSG ratio regulates several enzymes of glycolysis
gluconeogenesis. While, to our knowledge, inactivation of eno-
lase and 6-phosphogluconolactonase by GSSG had never been
reported, other enzymes identified in the present study were
already known to be regulated by GSSG, including aldolase (23),
ubiquitin-conjugating enzyme (24, 25), triosephosphate isomer-
ase (26), and pyrophosphatase (27). It is important to note that
inactivation by GSSG does not necessarily imply glutathionyla-
tion. In fact, GSSG, by the same thiol-disulfide exchange mech-
anism, can also lead to formation of intrachain disulfides in the
target protein, as it was elegantly shown for the OxyR transcrip-
tion factor in E. coli (28). However, our study, by showing that
these enzyme can incorporate 35S under oxidative stress in our
experimental model, strongly suggests that the effect of GSSG
reported previously is indeed caused by formation of glutathio-
nylated proteins.
Some of the proteins found to be glutathionylated belong to
the class of cytoskeletal proteins that are particularly abundant
in cells. The supramolecular organization of these proteins
depends on the presence of exposed -SH residues (29); the
modification of these groups by glutathionylation could be
relevant in their function, either by protecting them against
irreversible oxidation (30) or inhibiting polymerization (31).
Other proteins identified here might have important func-
tions. Nucleophosmin is involved in the assembly of ribosomal
proteins into ribosomes and has several roles in regulating cell
function and signaling (32). Cyclophilin is a chaperonin and a
peptidyl prolyl isomerase whereas ubiquitin-conjugating enzyme
is involved in the proteasomal degradation of proteins. Other
proteins with chaperone-like activity are the heat shock proteins
HSP60 and HSP70.
The consequences of glutathionylation obviously may be
different for the various proteins. In the case of enzymes, we
found that some of them are inhibited (enolase, 6-phosphoglu-
conolactase) whereas for others (cyclophilin) the activity does
not change with glutathionylation. In the literature, most studies
report an inhibition of enzyme activity by glutathionylation but
this obviously depends on the position of the cysteine undergoing
modification. For instance, HIV-1 protease can be inhibited or
stabilized by glutathionylation depending on which cysteine is
involved (33), whereas matrix metalloproteinases are activated
upon glutathionylation in the autoinhibitory domain (34).
Another important issue for which the present article can
provide useful information is whether there are proteins ‘‘con-
stitutively’’ glutathionylated (i.e., in the absence of oxidative
stress). In our study, at least three proteins appear as a row of
several spots, with different pI and the same molecular weight,
which likely result from posttranslational modifications. In fact,
addition of a glutamic acid residue (present in glutathione) is
likely to shift toward a more acidic pI in the isoelectric focusing
Fig. 1. Protein stain and glutathionylation pattern after two-dimensional electrophoresis of extracts from T cell blasts under basal conditions (control) or
oxidatively stressed with 1 mM diamide or 1 mM H2O2. 35S labeling of the intracellular GSH pool and electrophoresis were performed as described in Materials
and Methods. Proteins were separated based on pl (4-10 nonlinear gradient, left to right) and molecular weight (12% SDSPAGE, top to bottom). Coomassie
blue-stained maps are displayed (Upper) in comparison with fluorography (Lower). The experiment shown is representative of three and corresponds to
experiment 3 as reported in Table 1.
Fratelli et al. PNAS  March 19, 2002  vol. 99  no. 6  3507
BI
O
CH
EM
IS
TR
Y
dimension, depending on the buffering capacity of the protein
and the site of glutathionylation. In particular, cyclophilin A,
containing four cysteinyl residues, has been identified in five
spots, the most basic one being never labeled. Moreover the ratio
between the amount of protein in the different isoforms is
increased to the left in H2O2- and diamide-treated samples. This
Table 1. Summary of glutathionylated proteins identified
Protein
NCBI
number
Mol mass,
kDa
Spot no.
(Fig. 2)
Exp. where identified
by sequencing
Labeling (summary)
C D H
Stress proteins
HSP70-9B (mortalin-2) 4758570 70 1, 2 3  
Stress-induced phosphoprotein 1 400042 63 1 
HSP60 4504521 60 3, 4 3 
Enzymes
Inosine 5-monophosphate dehydrogenase 2 124419 55 5 3 
Protein disulfide isomerase* 1085373 48 2 
Enolase 1, alpha 4503571 47 8 1, 2, 3  †
(C term of) phosphoglycerate kinase 6456828 12, 25 2‡, 3 
Aldolase 229674 39 14, 17, 18 2§, 3 
6-Phosphogluconolactonase 6912586 27 22, 23 1, 3 
Phosphorylase kinase delta 13544110 16 41 3 
Triosephosphate isomerase 136060 26 1¶, 2 
Adenylate kinase 2 7434595 26 1
Peroxiredoxin 1 4505591 22 30 3 
dUTP pyrophosphatase 1071889 15 33 3 
Nudix-type motif 6 11095443 17 35 3  
Peptidylprolyl isomerase (cyclophilin A) 10863927 18 40 1.3  
Peptidylprolyl isomerase (cyclophilin A) 10863927 18 36–39 1, 3  
Cytochrome c oxidase 4758038 16 48 3 
Ubiquitin-conjugating enzyme E2N 4507793 17 42 3   
Cytoskeletal proteins
Vimentin 13629179 53 6, 7 1, 3 
Vimentin (fragment?) 13629179 53 10, 11 3 
Actin 13278939 41 13 1**, 2††, 3  
Tropomyosin 37424 29 19, 20 1, 3 
Transgelin, SM22 homolog calponin-like 4507357 22 29 1, 2, 3  
Cofilin 5031635 18 34 1‡‡, 3  
Myosin 189017 11 43 3 
Profilin 4826898 15 45 3 
Profilin 4826898 15 46 1, 2§§, 3 
Other
T complex protein 1 6094436 58 1¶¶ 
Lymphocyte-specific protein 1 2135579 36 9 3 
Nucleophosmin (dimer?) 13277532 23 15 1, 2, 3 
Nucleophosmin (fragment?) 13277532 23 32 3 
Hepatoma-derived growth factor 4758516 27 16 3 
Translation elongation factor 4503477 25 21 3 
Endoplasmic reticulum protein 5803013 29 23, 24 3 
SFR1 splicing factor 730773 28 1 
Ash protein 28876 18 26 3 
RNA-binding protein regulatory subunit 6005749 20 27, 28 1, 3  
My032 protein 12002006 15 31 3 
Fatty acid binding protein (psoriasis assoc.) 4557581 15 44 1, 2, 3 ? 
Beta galactoside soluble lectin (galectin) 227920 14 47 2, 3 
40S ribosomal protein S12 133742 14 1 ? 
NCBI, National Center for Biotechnology Information.
*Weak identification.
†Enolase labelling was different in the three experiments (very high in the first, null in the third).
‡Only in the place of spot 25 in experiment 3.
§Also two low molecular weight fragments.
¶In the place of phosphogluconolactonase and endoplasmic reticulum protein in experiment 3 (spot 24).
In the place of cofilin in experiment 1.
**One spot in the same position as experiment 3, one additional faint spot, more acidic, same molecular mass.
††In a different position than experiment 3 (smaller, more basic), probably a fragment.
‡‡In a different position from experiment 3 (more basic, same molecular mass).
§§In a different position from experiment 3 (smaller and more acidic).
¶¶In the place of inosine 5-monophosphate dehydrogenase 2 in experiment 3 (spot 5).
Galectin is also contained in spots a, b, and c.
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is particularly apparent in the spots marked as 38 and 39 in Fig.
2, which are almost equal in H2O2 and diamide, whereas 38 is
much less abundant than 39 in control. These findings are
consistent with the hypothesis that the different isoforms cor-
respond to the progressive glutathionylation of all of the sites
(from none - right, to 4 - left). Because multiple spots are present
also in controls, we suggest that an extensive glutathionylation
occurs even under basal conditions. A similar pattern was
observed with enolase (containing six potential glutathionyla-
tion sites), but with one difference. Indeed, labeling after
diamide treatment was very high in experiment 1 and zero in
experiment 3, suggesting that maximal glutathionylation was
already present under basal conditions in the last sample.
A different pattern can be observed for galectin, which is
present as a single spot in control (47 in Fig. 2). After diamide
treatment more than half of the protein disappears from this spot
and appears in three more acidic spots (the last barely detectable
after Coomassie blue stain; spots a, b, and c in Fig. 2). All of these
spots are strongly labeled, with increasing specific activity with
decreasing pI (i.e., in the presumably more extensively gluta-
thionylated isoforms).
Taken together, these observations suggest that both basal and
oxidation-induced glutathionylation occur in a significant por-
tion of total protein molecules, supporting the hypothesis that
this modification can significantly affect protein function.
In the present study, each experiment was performed by using
cells obtained from a different blood donor, and it is not
surprising that the redox status of the cells varies among different
subjects. The fact that proteins present in large amounts, such as
cyclophilin and enolase, are glutathionylated under resting con-
ditions suggests that these proteins can also be important as
glutathione stores. The hypothesis that some proteins are glu-
tathionylated under basal conditions is in agreement with earlier
reports showing that, in normal liver, 20–30 nmol of gluta-
thioneg of liver are present as mixed disulfides with proteins (1).
It is interesting to note that H2O2 did not induce a lower
labeling of the same proteins that were glutathionylated by
diamide treatment but rather produced a specific labeling pat-
Fig. 2. Two-dimensional protein map of T cell blasts. The position of the spots corresponding to the proteins identified by MS fingerprinting in experiment
3, and listed in Table 1, is marked on the map of the diamide-treated sample. Sequential numbers are either above the relevant spot (black) or below (white).
Table 2. Effect of GSSG on enzyme activity
Enzyme Without GSSG With GSSG
Enolase 1, alpha* 0.14  0.02 0.08  0.01
Cyclophilin† 0.32  0.01 0.31  0.01
6-Phosphogluconolactonase‡ 3300  100 1100  100
*PBMC extract (see Materials and Methods) was incubated 90 min with 5 mM
GSSG, then assayed for enolase activity. Activity is expressed as mol NADH
oxidizedmin per ml.
†Cyclophilin (2 M) was incubated 90 min with 5 mM GSSG, then assayed for
its activity at 10°C to minimize spontaneous isomerization of the substrate.
Activity is expressed as the rate of cis-trans isomerization (A390min).
‡Enzyme (150 M) was incubated 90 min with 7.5 mM GSSG, then assayed for
activity at 25°C. Activity is expressed as molmin per mg of protein.
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tern. For instance in cyclophilin, which is already basally gluta-
thionylated, labeling is brought about almost to the same extent
by H2O2 and diamide, whereas for galectin (which is not basally
glutathionylated) labeling with H2O2 is lower than with diamide,
suggesting a higher reactivity of the former. It is likely that the
susceptibility of different proteins to glutathionylation depends
on the oxidoreduction potential of the cysteines involved, as well
as on the stability of the mixed disulfide formed. For instance,
it was suggested that cysteine residues flanked by basic amino
acids might be particularly susceptible to glutathionylation as
well as to S-nitrosylation (7, 35).
Further studies should help determine the different suscep-
tibility of the various proteins to different degrees of oxidative
stress as well as their susceptibility to being substrates for
glutaredoxin and thioredoxin. The technique used here, com-
bining proteomics and redox modification, can help identifying
proteins specifically modified under pathological conditions.
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